Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Interest & Investment Income (2019 - 2025)

Revolution Medicines has reported Interest & Investment Income over the past 7 years, most recently at $21.3 million for Q4 2025.

  • Quarterly results put Interest & Investment Income at $21.3 million for Q4 2025, changed 0.32% from a year ago — trailing twelve months through Dec 2025 was $90.7 million (up 4.39% YoY), and the annual figure for FY2025 was $90.7 million, up 4.39%.
  • Interest & Investment Income for Q4 2025 was $21.3 million at Revolution Medicines, down from $22.1 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for RVMD hit a ceiling of $24.9 million in Q1 2025 and a floor of $223000.0 in Q3 2021.
  • Median Interest & Investment Income over the past 5 years was $10.7 million (2023), compared with a mean of $11.8 million.
  • Biggest five-year swings in Interest & Investment Income: plummeted 74.37% in 2021 and later skyrocketed 2237.42% in 2023.
  • Revolution Medicines' Interest & Investment Income stood at $237000.0 in 2021, then soared by 2042.19% to $5.1 million in 2022, then soared by 273.78% to $19.0 million in 2023, then increased by 11.85% to $21.2 million in 2024, then increased by 0.32% to $21.3 million in 2025.
  • The last three reported values for Interest & Investment Income were $21.3 million (Q4 2025), $22.1 million (Q3 2025), and $22.4 million (Q2 2025) per Business Quant data.